Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001422848-25-000134·Capital Research Global Investors
Schedule 13G ownership disclosure
GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK
Common Stock · CUSIP: 36266G107
Event date: 2025-05-30
- Filing-level shares
- 21,960,815.00
- Percent of class
- 4.8%
- Capital Research Global Investors
Shares: 21,960,815.00 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-25-000134
- Form type
- SCHEDULE 13G/A
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Jun 06, 2025
- Reporting period
- May 30, 2025
- Description
- Schedule 13G beneficial ownership